EOG
56
-2
AEE
64
4
HOG
33
4
CSX
57
6
F
47
4
SBUX
39
3
HPQ
57
-2
TMO
47
3
BBY
36
-4
ABBV
39
8
OI
42
5
ORCL
67
2
A
41
5
LEN
52
2
AIG
44
6
CAT
62
7
V
66
6
EQIX
62
2
HBI
55
-4
NUE
58
7
EOG
56
-2
AEE
64
4
HOG
33
4
CSX
57
6
F
47
4
SBUX
39
3
HPQ
57
-2
TMO
47
3
BBY
36
-4
ABBV
39
8
OI
42
5
ORCL
67
2
A
41
5
LEN
52
2
AIG
44
6
CAT
62
7
V
66
6
EQIX
62
2
HBI
55
-4
NUE
58
7
Financhill
Back

iLearningEngines 10K Form

Buy
70

AILE
iLearningEngines

Last Price:
1.49
Seasonality Move:
-1.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AILE News And Ratings

See the #1 stock for the next 7 days that we like better than AILE

AILE Financial Statistics

Sales & Book Value

Annual Sales: $309.17M
Cash Flow: $-9.41M
Price / Cash Flow: 0
Annual Sales: $0.02
Price / Book: 64.24

Profitability

EPS (TTM): -3.20800
Net Income (TTM): $-321.86M
Gross Margin: $215.28M
Return on Equity: 0%
Return on Assets: 0%

iLearningEngines Earnings Forecast

Key iLearningEngines Financial Ratios

  • The Gross Profit Margin over the past 3 years for AILE is 69.63%.
  • The Selling, General & Administrative Expenses for AILE have been equal to 34.27% of Gross Profit Margin.
  • The Research & Development expenses have been 31.52% of Revenue.
  • The Interest Expense is 57.68% of Operating Income.
  • The Net Earning history of AILE is 3.71% of Total Revenues.
  • Per Share Earnings over the last 3 years have been positive in 1 years.

iLearningEngines Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: AILE
Website: ilearningengines.com

Debt

Debt-to-Equity Ratio: 20.27
Current Ratio: 3.4
Quick Ratio: 3.4

Price-to-Earnings

Trailing P/E Ratio: 15.66
Forward P/E Ratio: 6.49

AILE Technical Analysis vs Fundamental Analysis

Buy
70
iLearningEngines (AILE) is a Buy

Is iLearningEngines a Buy or a Sell?

  • iLearningEngines stock is rated a Buy
    The current iLearningEngines [AILE] share price is $1.33. The Score for AILE is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.